Irradiated PD-L1 CAR-NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irradiated PD-L1 CAR-NK cells, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer [Phase 2]